Analysis finds risk factors for fluconazole-resistant Candida bloodstream infections, suggesting targeted treatments improve outcomes.
Azole exposure led to the development of fluconazole resistance in C. tropicalis BSI; hematologic malignancies, azole resistance, chronic obstructive pulmonary disease and having intravenous catheters increased mortality rate. The use of echinocandins or amphotericin B and catheter removal improved outcomes, underscoring the need for early resistance detection and targeted treatment.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: